CSF1R and plasma cell myeloma: Recently, Wang et al. explored the potential of targeting myeloma-associated macrophages using CSF1R-blocking mAb in mice suggesting that this approach may sensitize myeloma cells to chemotherapy and promote anti-myeloma immune responses.